Table 2

 Botto-Khoury 2 × 4 table for analysis of gene × environment interactions for GSTT1 genotypes versus current ETS exposure (⩾20 cigarettes)

Outcomes(1) GSTT1+ and ETS−(2) GSTT1+ and ETS+(3) GSTT1− and ETS−(4) GSTT1− and ETS+(5) Expected OR§/departure from expected OR (†‡)
In each cell the prevalence (%) of each outcome is shown with numbers of cases and total in parentheses. Adjusted odds ratio (OR) with 95% confidence intervals, adjusted for age, sex, city, family history of asthma, hay fever, eczema and ETS exposure, are compared with the reference cell (second line of each cell). Column 1 shows the reference group without smoke exposure and without a genetic defect in the respective GST enzyme; column 2 shows the effect of GST deficiency alone; column 3 shows the isolated effect of ETS exposure in children with the intact GST gene, respectively; column 4 shows the values for the combined effect of the respective GST deficiency and concomitant ETS exposure; column 5 shows the expected OR under the assumption of a multiplicative effect, the departure from the effect, and the statistical significance of the departure from the multiplicative model.
*p value <0.05 compared with the reference group.
†Departure from expected OR  =  OR in column 4 divided by the expected OR.
‡p value from the test for interaction from logistic regression model.
§Expected OR is the product of the ORs in columns 2 and 3.
Current asthma4.8 (59/1238)7.5 (5/67)3.5 (9/255)9.1 (1/11)
1.03.25 (1.14 to 9.27)*0.73 (0.35 to 1.50)4.10 (0.43 to 39.04)2.37/1.73 (p = 0.67)
Wheeze ever21.8 (266/1222)25.4 (17/67)19.1 (48/251)45.5 (5/11)
1.01.77 (0.92 to 3.42)0.84 (0.60 to 1.19)4.37 (1.17 to 16.39)*1.49/2.93 (p = 0.13)
Current wheeze7.9 (96/1222)13.4 (9/67)7.1 (18/253)18.2 (2/11)
1.02.61 (1.09 to 6.21)*0.90 (0.53 to 1.52)3.30 (0.61 to 17.91)2.34/1.41 (p = 0.71)
Current cough without cold15.4 (189/1228)16.2 (11/68)16.3 (41/252)45.5 (5/11)
1.01.50 (0.71 to 3.20)1.08 (0.74 to 1.56)6.72 (1.77 to 25.52)*1.62/4.15 (p = 0.05)